# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-071494
Filing Date
2023-12-19
Accepted
2023-12-19 16:15:16
Documents
20
Period of Report
2024-01-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | abio-20231213.htm iXBRL | DEF 14A | 716380
2 | GRAPHIC | img212962184_0.jpg | GRAPHIC | 9676
3 | GRAPHIC | img212962184_1.jpg | GRAPHIC | 9676
4 | GRAPHIC | img212962184_2.jpg | GRAPHIC | 20117
5 | GRAPHIC | img212962184_3.jpg | GRAPHIC | 18750
6 | GRAPHIC | img212962184_4.jpg | GRAPHIC | 9676
7 | GRAPHIC | img212962184_5.jpg | GRAPHIC | 978431
8 | GRAPHIC | img212962184_6.jpg | GRAPHIC | 268505
| Complete submission text file | 0000950170-23-071494.txt |  | 3919321

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | abio-20231213_pre.xml | EX-101.PRE | 10277
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | abio-20231213_def.xml | EX-101.DEF | 8536
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | abio-20231213.xsd | EX-101.SCH | 6918
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | abio-20231213_lab.xml | EX-101.LAB | 18417
15 | EXTRACTED XBRL INSTANCE DOCUMENT | abio-20231213_htm.xml | XML | 107891

Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 231497471
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)